V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260019105 | 260009986 | 1.87 | 67.2 | Curative (C) | 2015-08-19 | 2015-08-19 | CARBOPLATIN + IFOSFAMIDE + PACLITAXEL | null | null | 260008571 | POMB |
| 260019106 | 260014739 | 1.82 | 76.4 | Palliative (P) | 2016-08-03 | 2016-08-08 | Hydroxycarbamide | N | N | 260008930 | DASATINIB |
| 260019107 | 260010002 | 1.63 | 76.4 | Curative (C) | 2016-07-13 | 2017-01-11 | IFOSFAMIDE + PACLITAXEL | N | N | 260008975 | IVADO |
| 260019108 | 260010018 | 1.76 | 81.65 | Curative (C) | 2019-04-03 | 2019-05-04 | VIP | N | null | 260009422 | IFOSFAMIDE + PACLITAXEL |
| 260019109 | 260014746 | 1.77 | 102 | Adjuvant (A) | 2017-09-30 | 2017-10-03 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | N | 260009510 | MAP |
| 260019110 | 260010039 | 1.91 | 94.3 | Curative (C) | 2019-11-13 | 2019-11-22 | IPO | N | N | 260010054 | BLEOMYCIN + VINBLASTINE |
| 260019111 | 260010055 | 1.66 | null | Palliative (P) | 2018-03-22 | 2018-04-02 | DOCETAXEL + TRASTUZUMAB | N | null | 260010422 | DOCETAXEL |
| 260019112 | 260010066 | 1.67 | null | Palliative (P) | 2019-03-31 | 2019-04-06 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260010646 | EP |
| 260019113 | 260010090 | 1.62 | 65 | Curative (C) | 2015-08-16 | 2015-08-18 | CAPECITABINE + OXALIPLATIN | N | N | 260011894 | ESHAP R |
| 260019114 | 260010103 | 1.6 | 74 | Curative (C) | 2017-11-18 | 2017-11-24 | CHOP - 21 days | 2 | N | 260012314 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260019115 | 260014795 | null | 73.6 | null | 2016-06-26 | 2016-07-04 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 260014167 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260019116 | 260010149 | null | 81 | Curative (C) | 2020-01-27 | 2020-01-30 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260017955 | BLEOMYCIN + VINCRISTINE |
| 260019117 | 260019121 | 1.68 | 72.1 | null | 2018-06-02 | 2018-06-04 | Cyclophosphamide High Dose | null | null | 260019247 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 260019118 | 260014814 | 1.66 | 102 | Palliative (P) | 2016-12-15 | 2016-12-15 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 2 | N | 260019645 | VEIP |
| 260019119 | 260010176 | -1 | 82.2 | Curative (C) | 2014-03-20 | 2014-08-16 | Irinotecan + Temozolomide | N | N | 260020079 | EP |
| 260019120 | 260010185 | 1.84 | 66.7 | Palliative (P) | 2018-04-07 | 2018-04-09 | FMD | 02 | N | 260021633 | IVE |
| 260019121 | 260010201 | 1.76 | 63 | Curative (C) | null | 2018-01-01 | GEMCARBO | null | Y | 260028027 | DOCETAXEL |
| 260019122 | 260014829 | 1.6 | 61.8 | Adjuvant (A) | 2016-09-28 | 2016-09-28 | Chlorambucil | 2 | N | 260029516 | IVE |
| 260019123 | 260010218 | null | 85 | Curative (C) | 2017-04-05 | 2017-04-19 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260006709 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260019124 | 260010224 | 1.64 | 77 | Disease modification (D) | 2019-10-06 | 2019-10-12 | CARBO + THIOTEPA + TOPOTECAN | N | N | 260007145 | BLEOMYCIN |
| 260019125 | 260010226 | null | 77 | Palliative (P) | 2018-05-04 | 2018-06-27 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260007252 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260019126 | 260010228 | 1.76 | 66.8 | Palliative (P) | 2016-02-15 | 2016-06-11 | TRASTUZUMAB | N | N | 260007814 | NIVOLUMAB |
| 260019127 | 260010242 | 1.78 | 73 | Disease modification (D) | 2017-06-30 | 2017-06-30 | BLEOMYCIN + VINCRISTINE | 2 | N | 260019019 | CARBOPLATIN + PACLITAXEL |
| 260019128 | 260010246 | 1.8 | 95.8 | Curative (C) | 2019-11-22 | 2020-01-08 | Carboplatin + Etoposide IV 3 day | N | N | 260022120 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260019129 | 260006469 | 0 | null | Neo-adjuvant (N) | 2016-12-06 | 2017-10-10 | Rituximab | N | N | 260011994 | RITUXIMAB |
| 260019130 | 260006473 | 1.8 | null | Disease modification (D) | 2019-06-25 | 2019-06-25 | Rituximab (Maintenance) | 02 | null | 260012162 | RITUXIMAB |
| 260019131 | 260006479 | 1.64 | 66.6 | Palliative (P) | 2018-11-09 | 2018-11-10 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260012548 | RITUXIMAB |
| 260019132 | 260006483 | 1.68 | 91 | Disease modification (D) | null | 2015-08-25 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260012573 | RITUXIMAB |
| 260019133 | 260006496 | 1.78 | 91.2 | Disease modification (D) | 2017-10-10 | 2018-05-27 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260013256 | RITUXIMAB |
| 260019134 | 260012603 | null | 86 | Palliative (P) | 2017-08-08 | 2017-08-08 | Rituximab | 02 | null | 260015694 | RITUXIMAB |
| 260019135 | 260006596 | 1.7 | 90.2 | Palliative (P) | 2015-02-25 | 2015-02-26 | Rituximab (INTRAVENOUS Maintenance) | 02 | N | 260016181 | RITUXIMAB |
| 260019136 | 260006629 | 1.82 | 121.1 | Palliative (P) | 2016-10-04 | 2016-05-10 | Rituximab | N | N | 260016457 | RITUXIMAB |
| 260019137 | 260006744 | 1.63 | 68 | null | 2019-01-02 | 2019-01-09 | Rituximab | 02 | N | 260017618 | RITUXIMAB |
| 260019138 | 260012773 | 1.63 | 140 | Curative (C) | 2017-11-25 | 2018-05-25 | Rituximab | 02 | N | 260017953 | RITUXIMAB |
| 260019139 | 260006870 | 1.72 | null | null | 2016-11-17 | 2016-11-18 | Rituximab (Maintenance) | N | N | 260019086 | RITUXIMAB |
| 260019140 | 260006884 | 0 | 87 | Palliative (P) | 2019-05-05 | 2019-05-27 | Rituximab (Maintenance) | N | N | 260019190 | RITUXIMAB |
| 260019141 | 260006921 | 1.67 | 74.1 | Palliative (P) | 2017-10-04 | 2018-03-28 | Rituximab (INTRAVENOUS Maintenance) | N | null | 260019353 | RITUXIMAB |
| 260019142 | 260006956 | 1.76 | 78 | Disease modification (D) | 2020-05-25 | 2020-06-01 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260019486 | RITUXIMAB |
| 260019143 | 260006976 | 1.75 | 90.7 | Palliative (P) | 2017-06-15 | 2018-01-11 | Rituximab | 02 | N | 260019558 | RITUXIMAB |
| 260019144 | 260007009 | null | null | Palliative (P) | 2018-10-20 | 2019-05-02 | Rituximab | N | N | 260019681 | RITUXIMAB |
| 260019145 | 260007045 | 1.88 | null | null | 2018-01-23 | 2018-01-23 | Rituximab | N | N | 260019824 | RITUXIMAB |
| 260019146 | 260007122 | 1.5 | null | Curative (C) | 2018-01-17 | 2018-02-01 | Rituximab | null | null | 260020175 | RITUXIMAB |
| 260019147 | 260007320 | 1.71 | 76 | Adjuvant (A) | 2020-07-31 | 2021-01-27 | Rituximab | Y | N | 260021254 | RITUXIMAB |
| 260019148 | 260007396 | 1.72 | 59 | Disease modification (D) | 2018-01-14 | 2018-07-16 | Rituximab (Maintenance) | N | N | 260021680 | RITUXIMAB |
| 260019149 | 260007419 | 1.8 | null | Palliative (P) | 2018-10-18 | 2018-10-18 | Rituximab (Maintenance) | 02 | N | 260021811 | RITUXIMAB |
| 260019150 | 260007440 | 1.73 | 80.2 | Palliative (P) | 2017-09-26 | 2017-11-16 | Rituximab (Maintenance) | N | N | 260021909 | RITUXIMAB |
| 260019151 | 260007524 | 0 | 58.8 | Curative (C) | 2015-04-15 | 2016-11-29 | Rituximab | N | N | 260022340 | RITUXIMAB |
| 260019152 | 260007691 | null | 63 | Disease modification (D) | 2018-04-01 | 2018-04-19 | Rituximab | 02 | N | 260023249 | RITUXIMAB |
| 260019153 | 260016391 | 1.63 | 118.8 | Palliative (P) | 2017-08-06 | 2017-09-05 | Rituximab | 02 | N | 260023590 | RITUXIMAB |
| 260019154 | 260018595 | 0 | 88 | Disease modification (D) | 2016-08-08 | 2017-02-20 | Rituximab | N | N | 260023756 | RITUXIMAB |